| Prescription co-pay reduction program for diabetic employees. | |
| | |
MedLine Citation:
|
PMID: 20879904 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
The objective of this study was to examine the impact of reducing the prescription co-pay for diabetes medications on pharmacy utilization, medication adherence, medical utilization, and expenditures. The co-pay reduction involved placing all diabetic drugs and testing supplies on the lowest co-pay tier for one employer group. The sample comprised members with diabetes who were both continuously enrolled in the 12-month pre period and the 2 years following co-pay reduction. Measured outcomes included diabetic prescription utilization, medication adherence, medical utilization, and expenditures. Generalized estimating equations for repeated measures were used to estimate differences between the pre period and years 1 and 2, while adjusting for age, sex, and comorbidity risk. Diabetic prescription utilization and medication adherence increased by approximately 3.0% in year 1 and dropped in year 2. The increases were primarily in brand name diabetes medications, which increased by approximately 5%, while generic use decreased in both years. Decreases in emergency room visits and hospitalizations were also observed in both years, followed by a decrease in health care expenditures in year 2. Adherent members experienced greater decreases in emergency room visits following the co-pay reduction compared to nonadherent members. After the implementation of a co-pay reduction, a modest increase in adherence and use of diabetes medications was observed. There were some compensatory cost savings for the employer from lower medical expenditures in year 1. In addition to financial strategies, additional strategies to reinforce medication adherence are needed to gain and sustain more meaningful increases in prescription utilization. |
| | |
Authors:
|
Kavita V Nair; Kerri Miller; Jinhee Park; Richard R Allen; Joseph J Saseen; Vinita Biddle |
Related Documents
:
|
1363704 - Purification and characterization of aeromonas sobria ae24 pili: a possible new coloniz... 20637094 - Evaluation of medication adherence methods in the treatment of malaria in rwandan infants. 1600344 - Patient compliance with drug treatment--new perspectives on an old problem. 7834404 - Illness stage, concurrent medications, and other correlates of low testosterone in men ... 1363704 - Purification and characterization of aeromonas sobria ae24 pili: a possible new coloniz... 21931024 - Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Population health management Volume: 13 ISSN: 1942-7905 ISO Abbreviation: Popul Health Manag Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-30 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101481266 Medline TA: Popul Health Manag Country: United States |
Other Details:
|
Languages: eng Pagination: 235-45 Citation Subset: IM |
Affiliation:
|
School of Pharmacy, University of Colorado Denver , Denver, CO 80045, USA. Kavita.Nair@ucdenver.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Healthy coping: issues and implications in diabetes education and care.
Next Document: Economic impact of prior authorization policies for atypical antipsychotics in the treatment of schi...